KronoLife KronoLife Wins 1st Runner-up at CIB2024
KronoLife was awarded 1st Runner-up at the Innovation Challenge under the Cosmeceutical and Herbal Innovation with Business Link 2024 (CIB2024) program, an initiative designed to connect cosmetic, botanical extract, and herbal innovations with business expansion opportunities in both domestic and international markets.
The program was organized through the collaboration of Thailand Center of Excellence for Life Sciences (TCELS), Thailand Institute of Scientific and Technological Research (TISTR), and สำนักงานพัฒนาวิทยาศาสตร์และเทคโนโลยีแห่งชาติ (NSTDA), aiming to promote innovation that can be systematically translated into commercial applications.
The award recognized KronoLife’s cosmeceutical innovations, ZenoLase Evanesce Serum and ReverZase Regenerate Serum, developed under the Evidence-First Longevity framework. Both formulations are designed to address key cellular aging mechanisms, particularly senescent or Zombie cells and core pillars of biological aging.
These products have previously gained international recognition and were engineered to bridge biological mechanisms with explainable, verifiable outcomes, supporting real-world application and scalable market expansion.
KronoLife views this recognition at CIB2024 as a strong validation of its longevity innovation pathway one that prioritizes scientific rigor, measurable evidence, and sustainable commercial potential.